hidden pixel

Racivir Information

Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV.[1] It is the enantiomer of emtricitabine, meaning that the two compounds are mirror images of each other.

Emtricitabine, the enantiomer of racivir

References

  1. ^ "AIDSmeds.com - Racivir". http://www.aidsmeds.com/archive/Racivir_1590.shtml. Retrieved 2008-03-21.
Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)
Entry/fusion inhibitors (Discovery & development)
Reverse-transcriptase inhibitors (RTIs)
Nucleoside & Nucleotide (NRTI)
Non-Nucleoside (NNRTI) (Discovery & development)
Integrase inhibitors
Maturation inhibitors
Protease Inhibitors (PI) (Discovery and development)
1st generation
2nd generation
Combined formulations
Experimental agents
Uncoating inhibitors
Transcription inhibitors
Translation inhibitors
Other
Failed agents
°DHHS preferred first-line agent. ◊Formerly or rarely used agent.

: VIR

()/

/ (/, //)/

drugJ(, , , )
This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

Categories:

 

The above information uses material from Wikipedia and is licensed under the GNU Free Documentation License.
Some facts may not have been fully verified for accuracy. [Disclaimers]
This page was last archived by our server on Sun Feb 12 01:26:07 2012.
Displaying this page or its contents does not use any Wikimedia Foundation's resources.
The owners of this site proudly support the Wikimedia Foundation.

More Information Results for "Racivir"
[Hide]▼
'Racivir' Images
[Hide]▲